search
Back to results

TCM Daoyin in the Treatment of Patients With Anxiety State

Primary Purpose

Anxiety State

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
TCM Daoyin
Health education
Sponsored by
Shanghai University of Traditional Chinese Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Anxiety State focused on measuring TCM Daoyin, Anxiety, Randomized controlled trial

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Subject with a primary mental health complaint of anxiety. Anxiety 14≤HAMA-14≤29, Depression 7≤HAMD-17<14. Subject has no history of psychotropic medication or has been off medication for more than 6 months. Right-handed, aged 18 to 65, male or female. Subject has a clear mind and the ability to lead an independent life. Subject agrees to participate in fMRI scan and provide signed informed consent. Exclusion Criteria: Subject with definite clinical diagnosis of anxiety disorder and depression disorder by ICD-10. Subject with bipolar disorder, psychotic disorder (e.g., schizophrenia), organic mental disorder (e.g., Alzheimer's disease). Subject with alcohol abuse, substance dependence and suicidal ideation in past-year, or currently taking psychiatric medication, or current serious suicidal attempt. Subject with serious current unstable medical illness. Subject has claustrophobia, or any contraindication unable or unwilling to participate in fMRI scan. Subject is clinically unable to participate in TCM Daoyin training program. Subject is pregnant or lactating women.

Sites / Locations

  • Shanghai Qigong Research InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

TCM Daoyin intervention group

Health education control group

Arm Description

Participants randomized to TCM Daoyin intervention group receive health education plus a TCM Daoyin training program. The TCM Daoyin training program was a 12-week, instructor-led group training program.

Participants randomized to the health education control group only receive health education and no additional training program.

Outcomes

Primary Outcome Measures

14-item Hamilton Anxiety Rating Scale
The 14-item Hamilton Anxiety Rating Scale (HAMA-14) is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety. The HAMA-14 are rated on 5 grades ranging from 0(no symptom) to 4 (very severe). The total score ranges from 0 to 56. 29 or more on HAMA means severe anxiety disorders, 21 to 28 on HAMA means obvious anxiety disorders, 14 to 20 on HAMA means anxiety disorders, 8 to 13 on HAMA means suspicious anxiety disorders, 7 or less means no anxiety disorders.

Secondary Outcome Measures

17-item Hamilton Depression Rating Scale
The 17-item Hamilton Depression Rating Scale (HAMD-17) is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores indicate more severe depression. The HAMD-17 are rated on 5 grades ranging from 0(no symptom) to 4 (very severe). The total score ranges from 0 to 52. 25 or more on HAMD means severe depression disorders, 18 to 24 on HAMD means moderate depression, 13 to 17 on HAMD means mild depression disorders, 8 to 12 on HAMD means suspicious depression disorders, 7 or less means no depression disorders.
Depression, Anxiety and Stress Scale-21 item
The Depression, Anxiety and Stress Scale-21 item (DASS-21) is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively.
Depression, Anxiety and Stress Scale-21 item
The Depression, Anxiety and Stress Scale-21 item (DASS-21) is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively.
Depression, Anxiety and Stress Scale-21 item
The Depression, Anxiety and Stress Scale-21 item (DASS-21) is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively.
Functional magnetic resonance imaging (fMRI)
The fMRI scans will be employed to assess whether engaging in TCM Daoyin training program does or does not alter structural imaging and functional imaging of brain activation. Changes in Blood Oxygen Level Dependent (BOLD) Response is investigated in resting state fMRI and task fMRI.
Functional magnetic resonance imaging (fMRI)
The fMRI scans will be employed to assess whether engaging in TCM Daoyin training program does or does not alter structural imaging and functional imaging of brain activation. Changes in Blood Oxygen Level Dependent (BOLD) Response is investigated in resting state fMRI and task fMRI.
Immune function
CD3, CD4, CD8, IL-1β, IL-6 and TNF-α in blood samples will be measured to evaluate immune functions.
Adverse effects
During the intervention period, the doctors will ask specifically about, and record any adverse effect of the treatment that may have occurred.
Adverse effects
During the intervention period, the doctors will ask specifically about, and record any adverse effect of the treatment that may have occurred.

Full Information

First Posted
June 11, 2023
Last Updated
July 4, 2023
Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Shanghai Mental Health Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05932095
Brief Title
TCM Daoyin in the Treatment of Patients With Anxiety State
Official Title
TCM Daoyin in the Treatment of Patients With Anxiety State: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 13, 2023 (Actual)
Primary Completion Date
March 30, 2024 (Anticipated)
Study Completion Date
August 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Shanghai Mental Health Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In recent years, the number of people with symptoms of anxiety are on the rise. TCM Daoyin is a promising intervention for anxiety. This study is designed to allow researchers to better understand the changes in anxiety symptom, brain activity, and immune function during patients with anxiety states receiving TCM Daoyin intervention. Thus, the aims of the prospective randomized study are: (1) to examine the effects of TCM Daoyin training on reducing symptoms of anxiety, (2) to measure brain activity by using functional magnetic resonance imaging (fMRI), and (3) to assess Immune function.
Detailed Description
Anxiety is one of the most common mental health problems in the world. But there is a lack of sufficient no-drug intervention for relieving the anxious symptoms. The study focuses on mild and early anxiety disorder, which symptoms are not sufficiently severe, numerous, or persistent to justify a diagnosis of an anxiety disorder. TCM Daoyin is a form of mind-body exercise with a profound philosophical foundation rooted in Chinese culture. Previous studies have provided some evidence of beneficial effects on TCM Daoyin for anxiety, such as Baduanjin and Liuzijue. However, the effects and neurophysiology mechanisms of TCM Daoyin on patients with anxiety state are yet to be further investigated. This is a two-group prospective, randomized, assessor-blinded trial, planning to enroll 20 participants (10 for TCM Daoyin intervention group receiving health education plus a TCM Daoyin training program, and 10 for health education control group only receiving health education). The aims of the prospective randomized study are: (1) to examine the effects of TCM Daoyin training on reducing symptoms of anxiety, (2) to measure brain activity by using functional magnetic resonance imaging (fMRI), and (3) to assess Immune function.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety State
Keywords
TCM Daoyin, Anxiety, Randomized controlled trial

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study is a 12-week, randomized controlled trial. Patients with anxiety state are randomized to either TCM Daoyin intervention group or health education control group.
Masking
Outcomes Assessor
Masking Description
The outcome assessors were blinded to the group allocation of the participants.
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
TCM Daoyin intervention group
Arm Type
Experimental
Arm Description
Participants randomized to TCM Daoyin intervention group receive health education plus a TCM Daoyin training program. The TCM Daoyin training program was a 12-week, instructor-led group training program.
Arm Title
Health education control group
Arm Type
Active Comparator
Arm Description
Participants randomized to the health education control group only receive health education and no additional training program.
Intervention Type
Behavioral
Intervention Name(s)
TCM Daoyin
Other Intervention Name(s)
Qigong
Intervention Description
The TCM Daoyin training program consisted of two 90-min training classes and at least five 30-min at-home practice sessions per week for 12-weeks. All sessions included 10 min of warmup and 10 min of cooldown.
Intervention Type
Behavioral
Intervention Name(s)
Health education
Intervention Description
Health education is provided by psychologist and TCM doctor, including work, rest, diet and other basic programs.
Primary Outcome Measure Information:
Title
14-item Hamilton Anxiety Rating Scale
Description
The 14-item Hamilton Anxiety Rating Scale (HAMA-14) is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety. The HAMA-14 are rated on 5 grades ranging from 0(no symptom) to 4 (very severe). The total score ranges from 0 to 56. 29 or more on HAMA means severe anxiety disorders, 21 to 28 on HAMA means obvious anxiety disorders, 14 to 20 on HAMA means anxiety disorders, 8 to 13 on HAMA means suspicious anxiety disorders, 7 or less means no anxiety disorders.
Time Frame
Change from Baseline HAMA-14 at 12 weeks
Secondary Outcome Measure Information:
Title
17-item Hamilton Depression Rating Scale
Description
The 17-item Hamilton Depression Rating Scale (HAMD-17) is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores indicate more severe depression. The HAMD-17 are rated on 5 grades ranging from 0(no symptom) to 4 (very severe). The total score ranges from 0 to 52. 25 or more on HAMD means severe depression disorders, 18 to 24 on HAMD means moderate depression, 13 to 17 on HAMD means mild depression disorders, 8 to 12 on HAMD means suspicious depression disorders, 7 or less means no depression disorders.
Time Frame
Change from Baseline HAMD-17 at 12 weeks
Title
Depression, Anxiety and Stress Scale-21 item
Description
The Depression, Anxiety and Stress Scale-21 item (DASS-21) is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively.
Time Frame
Baseline
Title
Depression, Anxiety and Stress Scale-21 item
Description
The Depression, Anxiety and Stress Scale-21 item (DASS-21) is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively.
Time Frame
6 weeks
Title
Depression, Anxiety and Stress Scale-21 item
Description
The Depression, Anxiety and Stress Scale-21 item (DASS-21) is a self-rated assessment of patients' depressive, anxious and stress symptoms. Questions focus on depressive, anxious and stress symptoms during the past 7 days, and higher cumulative scores indicate more severe depression, anxiety and stress. Subscale scores are calculated as the sum of the responses to the seven items from each subscale multiplied by 2. The cutoffs for depression, anxiety, and stress are >9, >7, and >14, respectively.
Time Frame
12 weeks
Title
Functional magnetic resonance imaging (fMRI)
Description
The fMRI scans will be employed to assess whether engaging in TCM Daoyin training program does or does not alter structural imaging and functional imaging of brain activation. Changes in Blood Oxygen Level Dependent (BOLD) Response is investigated in resting state fMRI and task fMRI.
Time Frame
Baseline
Title
Functional magnetic resonance imaging (fMRI)
Description
The fMRI scans will be employed to assess whether engaging in TCM Daoyin training program does or does not alter structural imaging and functional imaging of brain activation. Changes in Blood Oxygen Level Dependent (BOLD) Response is investigated in resting state fMRI and task fMRI.
Time Frame
12 weeks
Title
Immune function
Description
CD3, CD4, CD8, IL-1β, IL-6 and TNF-α in blood samples will be measured to evaluate immune functions.
Time Frame
Change from Baseline immune function at 12 weeks
Title
Adverse effects
Description
During the intervention period, the doctors will ask specifically about, and record any adverse effect of the treatment that may have occurred.
Time Frame
6 weeks
Title
Adverse effects
Description
During the intervention period, the doctors will ask specifically about, and record any adverse effect of the treatment that may have occurred.
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject with a primary mental health complaint of anxiety. Anxiety 14≤HAMA-14≤29, Depression 7≤HAMD-17<14. Subject has no history of psychotropic medication or has been off medication for more than 6 months. Right-handed, aged 18 to 65, male or female. Subject has a clear mind and the ability to lead an independent life. Subject agrees to participate in fMRI scan and provide signed informed consent. Exclusion Criteria: Subject with definite clinical diagnosis of anxiety disorder and depression disorder by ICD-10. Subject with bipolar disorder, psychotic disorder (e.g., schizophrenia), organic mental disorder (e.g., Alzheimer's disease). Subject with alcohol abuse, substance dependence and suicidal ideation in past-year, or currently taking psychiatric medication, or current serious suicidal attempt. Subject with serious current unstable medical illness. Subject has claustrophobia, or any contraindication unable or unwilling to participate in fMRI scan. Subject is clinically unable to participate in TCM Daoyin training program. Subject is pregnant or lactating women.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ying Lu, Master
Phone
02154240423
Email
luwing_happy@163.com
Facility Information:
Facility Name
Shanghai Qigong Research Institute
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
021
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jie Li, doctor
Phone
02164383936
Email
lijietcm@163.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

TCM Daoyin in the Treatment of Patients With Anxiety State

We'll reach out to this number within 24 hrs